Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Phase II clinical results in psoriasis announced for IDEC-114

Sep. 6, 2002

SDZ-LAV-694: a topical antiproliferative agent with a favorable pharmacological profile

Sep. 6, 2002

Dusa reacquires rights to Levulan PDT

Sep. 5, 2002

Elidel receives positive health authority decision in 13 European countries

Aug. 21, 2002

Selective procollagen C-proteinase inhibitors presented by Pfizer

Aug. 21, 2002

Skin permeation of miconazole is enhanced by hydrogenated soybean lecithin and DDAIP formulations

Aug. 21, 2002

Periostat enters phase III trial for the treatment of rosacea

Aug. 21, 2002

Serono and Genentech sign marketing agreement for Raptiva, formerly Xanelim

Aug. 9, 2002

Inamed acquires rights to botulinum toxin type A

Aug. 8, 2002

Modex advances Allox through early-stage clinical testing

Aug. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...